(2018). Evolution of regenerative medicine business models. Clinical Therapeutics, 40(7), 1084-1094, ..
(2013). Finance as a ‘forgotten technological capability’ for promoting African local pharmaceutical manufacture. International Journal Of Technology Management And Sustainable Development, 12(2), 117-135, . Retrieved from http://oro.open.ac.uk/38594/.
(2015). Pharmaceutical Standards in Africa: The Road to Improvement and Their Role in Technological Capability Upgrading. In Making Medicines in Africa: The Political Economy of Industrializing for Local Health (pp. 224-242, ). Palgrave Macmillan. Retrieved from http://www.palgrave.com/page/detail/making-medicines-in-africa-maureen-mackintosh/?isb=9781137546463.
(2018). Health-industry linkages for local health: reframing policies for African health system strengthening. Health Policy And Planning, 33(4), 602-610, . Retrieved from https://academic.oup.com/heapol/article/33/4/602/4942503?guestAccessKey=64542eaf-2e56-4e0c-8758-261cec752018.
(2017). Local production of pharmaceuticals and health system strengthening in Africa: An Evidence Brief. Berlin: German Health Practice Collection (GHPC). Retrieved from http://www.health.bmz.de/ghpc/evidence_briefs/local_production_pharmaceuticals_health_system_strengthening_africa/index.html.
(2017). Private Sector Participation in Health Care in Zimbabwe: What’s the Value Added and Institutional Challenges?. Journal Of Healthcare Communications, 2(2). Retrieved from http://oro.open.ac.uk/48668/.
(2017). Proportionate and adaptive governance of innovative technologies (PAGIT). A framework to guide policy and regulatory decision making. Edinburgh: Innogen Institute Report..
(2016). Proportionate and Adaptive Governance of Innovative Technologies. The role of regulations, guidelines and standards - Summary Report to the British Standards Institution. London: BSI Standards Ltd..
(2017). Private Sector Participation in Health Care in Zimbabwe. Journal Of Healthcare Communications, 2(2)..
(2019). Understanding the Emergence and Evolution of New Business Models in the UK Regenerative Medicine Sector. Technology Analysis And Strategic Management..